This announcement is a separate document:
科伦药业：上海信公轶禾企业管理咨询有限公司关于四川科伦药业股份有限公司2021年限制性股票激励计划第二个解除限售期解除限售相关事项之独立财务顾问报告
Sichuan Kelun Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the lifting of sales restrictions during the second period of the 2021 Restricted Stock Incentive Plan of Sichuan Kelun Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated